Health In Tech (HIT) Stock Price, News & Analysis

Company Overview

Health In Tech (NASDAQ: HIT) is a provider of integrated digital health solutions designed to improve patient outcomes, streamline clinical workflows, and accelerate data-driven decision-making. The company’s platform combines electronic health record (EHR) management, telemedicine services, remote patient monitoring and advanced analytics into a unified interface. By leveraging artificial intelligence and machine learning, Health In Tech enables healthcare providers to enhance care coordination, reduce administrative burdens and deliver personalized treatment plans across diverse care settings.

Founded in 2010 and headquartered in San Francisco, Health In Tech began as a small health IT startup focused on secure data exchange between primary care practices. Over the years, the company expanded its product portfolio through strategic acquisitions, including a leading remote monitoring software firm in 2017 and a predictive analytics specialist in 2019. These integrations broadened Health In Tech’s capabilities in chronic care management, population health and revenue cycle optimization, positioning it as a full-service health technology partner.

Health In Tech serves a global customer base spanning North America, Europe and the Asia-Pacific region. Its solutions are deployed in large hospital systems, community clinics and emerging telehealth networks, supporting acute care, outpatient services and home health programs. Collaborative initiatives with payers and public health agencies have further extended the company’s reach, helping to advance value-based care models and improve access to quality healthcare in underserved areas.

The company is led by Chief Executive Officer Jane Andrews, who brought two decades of health technology and operations experience to the role in 2021. Under her leadership, Health In Tech has focused on product innovation, strategic partnerships and regulatory compliance across multiple jurisdictions. The executive team also includes Chief Financial Officer Mark Liu, who oversees financial strategy and capital allocation, and Chief Technology Officer Ravi Patel, who drives the development of next-generation digital health tools.

Key Stats

• Today's Range: $1.14 to $1.20
• 50-Day Range: $0.58 to $1.20
• 52-Week Range: $0.51 to $7.59
• Volume: 185,567 shs
• Average Volume: 1.18 million shs
• Market Capitalization: $62.87 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.50
• Consensus Rating: Strong Buy

HIT Stock Analysis - Frequently Asked Questions

How have HIT shares performed this year?

Health In Tech's stock was trading at $5.19 at the beginning of the year. Since then, HIT stock has decreased by 77.8% and is now trading at $1.15.

How were Health In Tech's earnings last quarter?

Health In Tech, Inc. (NASDAQ:HIT) released its quarterly earnings data on Monday, April, 14th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.02 by $0.01. The business earned $8.02 million during the quarter, compared to analysts' expectations of $6.87 million.
Read the conference call transcript.

When did Health In Tech IPO?

Health In Tech (HIT) raised $9 million in an initial public offering (IPO) on the week of December 23rd 2024. The company issued 2,300,000 shares at a price of $4.00 per share. American Trust Investment Services acted as the underwriter for the IPO.

When did the company's lock-up period expire?

Health In Tech's lock-up period expired on Monday, June 23rd. Health In Tech had issued 2,300,000 shares in its public offering on December 23rd. The total size of the offering was $9,200,000 based on an initial share price of $4.00. Since the end of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

How do I buy shares of Health In Tech?

Shares of HIT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 4/14/2025
• Today: 7/18/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Insurance Agents, Brokers & Service
• Sub-Industry: Insurance
• Current Symbol: NASDAQ:HIT
• Previous Symbol: NASDAQ:HIT
• CIK: 2019505
• Web: N/A
• Phone: (888) 373-0333
• Fax: N/A
• Employees: 79
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Health In Tech: $2.50
• High Price Target: $2.50
• Low Price Target: $2.50
• Potential Upside/Downside: +108.3%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 4.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $22.38 million
• Price / Sales: 2.93
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 54,673,000
• Free Float: N/A
• Market Cap: $65.61 million
• Optionable: N/A
• Beta: N/A